PharmaCyte Biotech PMCB Stock
PharmaCyte Biotech Price Chart
PharmaCyte Biotech PMCB Financial and Trading Overview
| PharmaCyte Biotech stock price | 0.73 USD |
| Previous Close | 0.83 USD |
| Open | 0.83 USD |
| Bid | 0.57 USD x 200 |
| Ask | 1.04 USD x 200 |
| Day's Range | 0.79 - 0.84 USD |
| 52 Week Range | 0.63 - 1.51 USD |
| Volume | 89.82K USD |
| Avg. Volume | 198.6K USD |
| Market Cap | 8.59M USD |
| Beta (5Y Monthly) | 0.457 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PMCB Valuation Measures
| Enterprise Value | -11075870 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.1055264 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.22293119 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
PharmaCyte Biotech Stock Price History
| Beta (5Y Monthly) | 0.457 |
| 52-Week Change | -27.26% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.51 USD |
| 52 Week Low | 0.63 USD |
| 50-Day Moving Average | 0.75 USD |
| 200-Day Moving Average | 0.84 USD |
PMCB Share Statistics
| Avg. Volume (3 month) | 198.6K USD |
| Avg. Daily Volume (10-Days) | 229.58K USD |
| Shares Outstanding | 10.74M |
| Float | 9.96M |
| Short Ratio | 1.88 |
| % Held by Insiders | 5.74% |
| % Held by Institutions | 9.01% |
| Shares Short | 469.9K |
| Short % of Float | 4.62% |
| Short % of Shares Outstanding | 4.37% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1550 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | April 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -6.75% |
| Return on Equity (ttm) | -8.23% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7486426 USD |
| Diluted EPS (ttm) | -0.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.54M USD |
| Total Cash Per Share (mrq) | 1.91 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 12.332 |
| Book Value Per Share (mrq) | 3.589 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4800723 USD |
| Levered Free Cash Flow (ttm) | -1694738 USD |
Profile of PharmaCyte Biotech
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 3960 Howard Hughes Parkway |
| ZIP | 89169 |
| Phone | 917 595 2850 |
| Website | https://pharmacyte.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Q&A For PharmaCyte Biotech Stock
What is a current PMCB stock price?
PharmaCyte Biotech PMCB stock price today per share is 0.73 USD.
How to purchase PharmaCyte Biotech stock?
You can buy PMCB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaCyte Biotech?
The stock symbol or ticker of PharmaCyte Biotech is PMCB.
Which industry does the PharmaCyte Biotech company belong to?
The PharmaCyte Biotech industry is Biotechnology.
How many shares does PharmaCyte Biotech have in circulation?
The max supply of PharmaCyte Biotech shares is 10.74M.
What is PharmaCyte Biotech Price to Earnings Ratio (PE Ratio)?
PharmaCyte Biotech PE Ratio is now.
What was PharmaCyte Biotech earnings per share over the trailing 12 months (TTM)?
PharmaCyte Biotech EPS is -0.89 USD over the trailing 12 months.
Which sector does the PharmaCyte Biotech company belong to?
The PharmaCyte Biotech sector is Healthcare.
PharmaCyte Biotech PMCB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}